title: [Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
authors.affiliation: Heart and Bloodvessel Centre, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China.
authors.forename: Lei
authors.initials: L
authors.lastname: Wang
authors.forename: Liang
authors.initials: L
authors.lastname: Cui
authors.forename: Jia-ping
authors.initials: JP
authors.lastname: Wei
authors.forename: Guang-ping
authors.initials: GP
authors.lastname: Li
authors.forename: Guo-xian
authors.initials: GX
authors.lastname: Qi
authors.forename: Yu-ming
authors.initials: YM
authors.lastname: Hao
authors.forename: Wen-zhi
authors.initials: WZ
authors.lastname: Wang
authors.forename: Hui-min
authors.initials: HM
authors.lastname: Li
authors.forename: Jun
authors.initials: J
authors.lastname: Liu
authors.forename: Dong-ju
authors.initials: DJ
authors.lastname: Jiang
authors.forename: Yu-dong
authors.initials: YD
authors.lastname: Zhang
mesh_terms: D000368:Aged; D002316:Cardiotonic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004280:Dobutamine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D006835:Hydrazones / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011724:Pyridazines / Q000008:administration & dosage / Q000627:therapeutic use*; D000077464:Simendan; D016896:Treatment Outcome
chemical_list: D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan; D004280:Dobutamine